Status:
UNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics
Lead Sponsor:
Heba Momen kamel
Conditions:
Adenovirus
Eligibility:
All Genders
Brief Summary
BACKGROUND: The 243 amino acid E1A encoded by the left end of the human adenovirus (Ad) type 2 or 5 genome has been studied in various contexts including as a model cooperating oncoprotein , an apopt...
Detailed Description
BACKGROUND: TThe 243 amino acid E1A protein (also known as small E1A protein, transforming E1A protein) encoded by the left end of the human adenovirus (Ad) type 2 or 5 genome has been studied in var...
Eligibility Criteria
Inclusion
- \- All patients who are positive for adenovirus
Exclusion
- \- immune comprised patients
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03325517
Start Date
November 1 2017
End Date
September 1 2019
Last Update
October 30 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.